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Items for this week’s EPI Update include: 
  
 H1N1 quick points for health care providers 
 Information on morbidity and mortality in Iowa due to H1N1 
 Use of CSL 2009 H1N1 monovalent influenza vaccine 
 Keeping holiday cooking safe 
 Meeting announcements and training opportunities 
  
H1N1 quick points for health care providers 
 People age 65 and older are NOT in a vaccine target group, regardless of 
health status or underlying chronic conditions because of their low risk of 
developing 2009 H1N1. Please do not tell them to go get the vaccine, 
as they will be turned away at the immunization clinic. If and when enough 
vaccine is available for anyone of any age who wishes to be vaccinated, 
this will be made public. See www.cdc.gov/h1n1flu/65andolder.htm  
 The risk of transmission of virus from the nasal spray vaccine is minimal, 
thus almost all health care workers, including those working in NICU, can 
safely receive the live attenuated influenza vaccine (LAIV). Only those 
HCPs working with patients in a protected environment (i.e. stem cell 
transplant units) are recommended to receive inactivated vaccine. See 
www.cdc.gov/h1n1flu/vaccination/nasalspray_qa.htm 
 Children 6 months through 9 years of age need two doses of influenza 
A(H1N1) monovalent vaccine. The two doses should be separated by four 
weeks (28 days) or longer. This spacing interval applies to both the 
injectable and mist vaccine presentations.   
 See www.cdc.gov/H1N1flu/vaccination/top10_faq.htm 
 People age 65 and older should be considered for empirical treatment with 
antivirals if they get sick with either seasonal or 2009 H1N1 flu this 
season. See www.cdc.gov/h1n1flu/highrisk.htm. 
 Recently, pneumococcal infections have been identified as an important 
complication in severe and fatal cases of 2009 H1N1. All children younger 
than 5 years of age should receive the pneumococcal conjugate vaccine 
(PCV7) according to existing recommendations. Persons up to 64 years of 
age with high risk medical conditions, and all those 65 and older should 
receive a pneumococcal vaccine. See 
www.cdc.gov/h1n1flu/vaccination/provider/provider_pneumococcal.htm.   
 It is ok to give infants breast milk while the mother is sick with 2009 H1N1 
or seasonal flu; however, infants are thought to be at higher risk for severe 
illness from 2009 H1N1 infection, so precautions should be taken. See 
www.cdc.gov/h1n1flu/infantfeeding. 
 People with diabetes are at increased risk for severe disease and 
complications, such as hospitalization and death, from both seasonal flu 
and 2009 H1N1 flu. CDC recommends that people with all types of 
diabetes who are 6 months through 64 years get a 2009 H1N1 flu shot. 
See www.cdc.gov/h1n1flu/diabetes/. 
  
Information on morbidity and mortality in Iowa due to H1N1 
Hospitalizations by age groups: 
 5 to 18 years of age (24 percent) 
 25 to 49 years of age (22 percent) 
 50 to 64 years of age (15 percent) 
 1 to 4 years of age (15 percent) 
 Younger than 12 months of age (9 percent) 
 Greater than 64 years of age (8 percent) 
 18 to 24 years of age (7 percent) 
  
One percent of hospitalized women were pregnant. 
  
Hospitalizations by underlying medical conditions: 
 immune-compromised, such as cancer 
 respiratory conditions, such as asthma 
 neuromuscular conditions  
  
More than 50 percent of those hospitalized were overweight or obese, which may be associated 
with medical conditions, such as diabetes, which increase the chance of complications from 
H1N1. 
  
Mortality by age groups (all major racial/ethnic groups have been affected):  
 nearly half (11) of the deaths have occurred in adults ages 25 to 49 
 five deaths were in the 50 to 64 age range 
 three deaths were adults ages 18 to 24 
 there was one death each in children ages 0 to 18 
 there was one death in adults greater than age 64 
  
Mortality by underlying medical conditions: 
 pulmonary/respiratory conditions 
 immune-compromised conditions, including cancer 
 neuromuscular conditions 
 diabetes and renal (kidney) disease 
  
About half of the fatalities were obese or morbidly obese; obesity by itself is not identified as a 
risk factor; however, those who are obese, and especially those who are morbidly obese, often 
have underlying conditions that may put them at higher risk of complications. 
Two of the H1N1 fatalities had no known underlying risk factors from medical 
complications. 
  
Use of CSL 2009 H1N1 monovalent influenza vaccine 
On November 11, 2009, the FDA expanded the approved use of CSL’s seasonal 
and 2009 H1N1 monovalent influenza vaccines to include children aged 6 
months and older.  Both vaccines had previously been approved only for use in 
adults, aged 18 years and older.   
  
Pre-filled syringe presentation 0.5mL:   
CSL H1N1 pre-filled syringe vaccine, 0.5mL, may be used in individuals 3 years 
of age and older.    
  
Multi-dose vial presentation 5mL/vial:   
CSL’s H1N1multi-dose vial vaccine is licensed for use in individuals aged 6 
months and older. 
  
Dosing: 
6 - 35 months                                  0.25mL dose 
3 years of age and older                0.5mL dose 
  
The updated 2009 H1N1 monovalent influenza vaccine package insert is 
available on the Food and Drug Administration (FDA) Web site at 
www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM18
2401.pdf 
  
Keeping holiday cooking safe 
Thanksgiving dinner often means cooking for a large number of people and 
cooking less common foods, such as a 20 pound turkey. Information for health 
care providers and their patients can be found at 
www.cdc.gov/foodsafety/holidaycook.htm. 
  
Meeting announcements and training opportunities 
  
2009 National Laboratory Network Flu Update: Utility of Research Influenza Diagnostic Tests 
(RIDTs) for H1N1 & Seasonal Influenza.  
Are Rapid Influenza Diagnostic Tests (RIDTs) useful in diagnosing influenza A (H1N1) and 
seasonal influenza? Audience: This intermediate-level program is appropriate for clinicians, 
laboratory personnel and physicians from physician office laboratories and medical clinics. This 
program is available 24/7. Register online at www.nltn.org/210-09.htm. 
  
G-290 Public Information Officer (PIO) 
Nov. 11-12, 8 a.m. to 5 p.m. Norwalk, Iowa 
Dec. 1-2, 8 a.m. to 5 p.m. Mason City, Iowa  
Dec. 10-11, 8 a.m. to 4 p.m. Atlantic, Iowa  
This free 16-hour course will assist participants with building the skills 
needed to be a full or part-time public information officer. Skills addressed 
include oral and written communications, understanding and working with 
the media, and the basic tools and techniques PIOs need. It covers the 
latest technology available so that PIOs can use those tools comfortably, 
and to their advantage. Register by contacting Lindsay Bollard at 515-574-
1263 or bollard@iowacentral.com  Space is limited, so please register as 
soon as possible. 
  
Biosafety and Biosecurity: Minimizing the Risks in the Laboratory 
Offered on January 13, 2010, at the University Hygienic Laboratory 
Ankeny facility, this course will cover the differences between biosafety 
and biosecurity, utilizing biosafety level (BSL) 3 practices in a BSL2 lab, 
and information on conducting risk assessments for both biosafety and 
biosecurity.  For more information contact Rich Bonar at 319 335 4500 or 
richard-bonar@uiowa.edu.  
  
Have a healthy and happy week! 
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